Sanofi India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sanofi India Limited has filed a routine compliance certificate with NSE and BSE confirming that its Registrar and Transfer Agent (RTA), MUFG Intime India Private Limited, processed all securities received for dematerialization during Q4 (January-March 2026). The RTA confirmed that dematerialization requests were either confirmed or rejected and submitted to deposositories within prescribed timelines. The security certificates were mutilated and cancelled after verification, and depository names were substituted in the register of members. This is a standard quarterly regulatory filing required under SEBI regulations for all listed companies.
This is a routine administrative filing with no direct impact on Sanofi India's stock price or shareholder value. It simply confirms that the company's share dematerialization processes are compliant with SEBI regulations and functioning normally.